HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial.

J Viral Hepat · 2014 · PMC4166695 · PMID 24750327

Europe PMC DOI

hedged sentence

0.1730

closest p · 3.5× alpha

0.1730

boldest claim

The sentences

did not reach statistical significanceP = 0.173not close (p > 0.1)

The rate of SVR among patients with a previous relapse was higher with P/R + V (27.3%) than with P/R alone (12.5%), although the difference did not reach statistical significance ( P = 0.173).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.